WO1996006946A1 - Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface - Google Patents

Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface Download PDF

Info

Publication number
WO1996006946A1
WO1996006946A1 PCT/US1995/010630 US9510630W WO9606946A1 WO 1996006946 A1 WO1996006946 A1 WO 1996006946A1 US 9510630 W US9510630 W US 9510630W WO 9606946 A1 WO9606946 A1 WO 9606946A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
nucleic acid
film
electrode
label
Prior art date
Application number
PCT/US1995/010630
Other languages
French (fr)
Inventor
Allen J. Bard
Xiao-Hong Xu
Original Assignee
Igen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igen, Inc. filed Critical Igen, Inc.
Priority to JP8508822A priority Critical patent/JPH10509025A/en
Priority to EP95930881A priority patent/EP0777741A4/en
Priority to AU34103/95A priority patent/AU703344B2/en
Publication of WO1996006946A1 publication Critical patent/WO1996006946A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Definitions

  • the present invention relates to the diagnostic field, and especially nucleic acid diagnostics.
  • the present invention relates to a probe or sensor having a film containing metal centers, its preparation where a single-strand or double-strand nucleic acid sequence is immobilized thereon on, and its use in the subsequent
  • nucleic acid diagnostics based on a surface designed modified electrical sensor, i.e., chips or electrode
  • immobilization and hybridization of nucleic acid such as DNA on a self- assembled thin film via surface reaction is also useful in studying molecular recognition of DNA.
  • Nucleic acid diagnostics has become an important area in molecular biology and biotechnology studies, with applications to the determinations of disease and food contaminating organisms and in forensic and environmental investigations.
  • the development of new DNA biosensors has led to the application of several detection techniques such as optical methods (e.g., luminescence, ellipsometry and pseudo- Brewster angle reflectometry), piezoelectric devices (e.g., SAW, QCM) , and electrochemical techniques (e.g., CV and SWV).
  • optical methods e.g., luminescence, ellipsometry and pseudo- Brewster angle reflectometry
  • piezoelectric devices e.g., SAW, QCM
  • electrochemical techniques e.g., CV and SWV.
  • CV and SWV electrochemical techniques
  • Suitable labels comprise
  • electrochemiluminescent compounds including organic compounds and metal chelates.
  • electrochemiluminescent ruthenium- and osmium-containing labels have been used in methods for detecting and quantifying analytes of interest in liquid media (U.S. Patent Nos. 5,310,687; 5,238,808; and 5,221,605).
  • electrogenerated chemiluminescence (ECL) measurements to the detection of solution phase DNA intercalated with ruthenium-containing labels has been described (Carter, M.T. et al. (1990) Bioconjugate Chem 2:257-263).
  • ECL electrogenerated chemiluminescence
  • solution phase analytes such as DNA has several drawbacks relative to detection of analytes absorbed to solid surfaces.
  • the advantages for detecting DNA via solid phase techniques as opposed to solution techniques are: (1) more sensitive (detection of monolayer quantities); (2) easier to separate DNA from sample (avoid interferences); and (3) possibility of detection of several different DNA in single analysis, with localized probes, e.g., as in sequencing studies.
  • chemiluminescent labels are used in immunochemical applications where the labels are excited into a luminescent state by reaction of the label with H 2 O 2 and an oxalate.
  • H 2 O 2 oxidatively converts the oxalate into a high energy derivative, which then excites the label. It is expected, that in principle, the H 2 O 2 and an oxalate reaction scheme should work with any luminescent material that is stable under the oxidizing conditions of the assay, and can be excited by the high energy oxalate derivative.
  • the present invention provides a biosensor and its use for electrogenerated chemiluminescent detection of nucleic acid absorbed to a solid surface via the use of ruthenium- and osmium-containing chemiluminescent labels.
  • An object of the present invention is to provide a film containing an aluminum (III) alkanebisphosphonate layer having metallic aluminum centers, i.e., ionic aluminum
  • the aluminum (III) alkanebisphosphonate can be provided as a biosensor having a coating of Al 2 (C 4 BP) to bond to SS-DNA or ds-DNA.
  • a further object of the present invention is to provide a biosensor in the form of chips or electrodes with adsorbed DNA that is labelled with a luminescent label, such as an osmium or ruthenium moiety.
  • a still further object of the present invention is to prepare a biosensor by treating a silicon wafer to form a chromium layer and juxtaposed gold layer, then contacting the layered wafer with an anchoring agent; and subsequently immersing the product in Al(NO 3 ) 3 , bisphosphonic acid
  • Another object of the present invention involves the detection of a nucleic acid by labelling with luminescent metal chelates.
  • a further object of the present invention is to apply electrogenerated chemiluminescent techniques to a plurality, i.e., arrayed, oligonucleotide probes.
  • Fig. 1 shows a schematic representation of the silicon electrode of the present invention containing ionic aluminum Al(III) sites.
  • Fig. 2 shows immobilization of ds-DNA on a
  • Figs. 3A-3C show first (A), second (B), and third
  • Figs. 4A-4C show schematic representations of
  • Figures 5A-5C show a cyclic voltammogram (Fig. 5A);
  • FIG. 5B an emission-potential transient of the Al 2 (C 4 BP) ⁇ -1 ss-DNA in the same solution
  • Figure 6 shows an emission-time transient for the
  • FIGS 7A and 7B show ECL emission-potential
  • FIGS 8A and 8B show ECL emission-potential
  • Figures 9A-9C show TEM images of Au substrate coated on a Formvar film on a #400 Cu grid (Fig. 9A); the Al 2 (C 4 BP) film on the Au substrate
  • FIG. 9B immobilized calf thymus ds-DNA on the Al 2 (C 4 BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution for - 4 h (Fig. 9C).
  • Figures 10A-10C show TEM images of the Al 2 (C 4 BP)
  • Fig. 10A immobilized calf thymus ds-DNA on the Al 2 (C 4 BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution, for -4 h (Fig. 10B);
  • FIG. 10C Figures 11A - 11B show sequencing via array
  • the present invention relates to a sensor and method of detecting nucleic acids using the sensor.
  • the sensor can be a chip, electrode, or an appropriately modified surface for- adsorbing ss-DNA or ds-DNA.
  • the nucleic acids detected by the method of the present invention include DNA, cDNA or any synthetic variant thereof.
  • a nucleic acid as used throughout the specification and in the claims is meant DNA or any synthetic variant thereof.
  • DNAs detectable by the present method include chromosome DNA, plasmid DNA, viral DNA, bacterial DNA and recombinant DNA.
  • the length of nucleic acid sequence capable of detection by the present method ranges from about 2.7 nm to about 200 nm. In a preferred embodiment, the nucleic acid sequence ranges from 8 base pair (bp)
  • nucleotides to 3,000 base pair nucleotides In a most preferred embodiment ranges from about 30 bp nucleotides to 1,500 bp nucleotides.
  • the nucleic acid sequence to be detected may be of purified nucleic acid or may be present in a biological sample.
  • Biological samples in which nucleic acids can be detected using the method of the present invention include but are not limited to biological fluids, e.g., serum, saliva, hair, skin, etc.
  • the nucleic acid can be purified from a sample using methods known to those skilled in the art (Current Protocols in
  • the aluminum (III) alkanebisphosphonate preferably used is a Al 2 (C 4 BP), also [Al 2 C 4 BP], film bearing biosensor and is prepared as follows. Silicon wafers were soaked in trichloroethylene for 30 min, rinsed twice with 2-propanol, rinsed with excess amount of deionized water, and then dried with a stream of dry nitrogen. The clean silicon wafers were primed with a 50 A chromium layer followed by deposition of a 2000 A gold layer. Chromium and gold targets (99.999%) were used to sputter the films onto the wafers in a MRC Model 8620 system at 10 -2 torr. Other techniques, such as chemical vapor deposition (CVD) to apply the Au or Cr layers, can also be used.
  • CVD chemical vapor deposition
  • the gold surface supported on the silicon wafers was cleaned with hot chromic acid (saturated K 2 Cr 2 O 7 in 90% H 2 SO 4 ) for -10 s and then rinsed with copious amounts of water. This process was repeated until the surface contact angle with water was less than 15°.
  • the clean Au surface was then immediately soaked in an anchoring agent, 0.5 mM 4- mercaptobutylphosphonic acid (MBPA) solution in absolute ethanol for -24 h. See Fig. 1.
  • MBPA 4- mercaptobutylphosphonic acid
  • the "spacer” may range from 2 to 16 carbons in length.
  • the sensor described above is used by:
  • step (a) detecting the nucleic acid metal label chelates formed in step b) via electrogenerated chemiluminescence of said chelates.
  • the film to which the nucleic acid is adsorbed should contain metal ions which are suitably spaced on the surface of the film to allow interaction of the metal with the phosphate backbone of the nucleic acid sequence.
  • metal centers suitable for use in binding to nucleic acid phosphate groups are aluminum, lanthanum, and zirconium.
  • the film contains an aluminum Al (III) metal center.
  • the nucleic acid adsorbed to the film in step (a) of the method of the present invention may be either double- stranded or single-stranded.
  • the adsorbed single-stranded nucleic acid is then hybridized to a complementary single- stranded nucleic acid sequence.
  • Conditions of hybridization are utilized which promote base pairing between the single- stranded DNA adsorbed to the film in its complementary sequence.
  • Factors influencing hybridization between nucleic acid sequences are known to those skilled in the art and include salt concentration of the hybridization solution, hybridization temperature and stringency of post-hybridization washes.
  • the complementary single-stranded nucleic acid sequence hybridized with the nucleic acid adsorbed to the film may be unlabeled or labeled with a luminescent metal label.
  • Suitable luminescent labels include ruthenium- and osmium- containing labels where ruthenium or osmium are bound to at least one polydentate ligand. If the metal has greater than one polydentate ligand, the polydentate ligands may be the same or different.
  • ECL active labels can also be utilized that emit at different wave lengths such as organic ECL labels, e.g. sulfonated-9,10-diphenylanthracene.
  • Polydentate ligands of either ruthenium or osmium include aromatic and aliphatic ligands.
  • Suitable aromatic polydentate ligands include aromatic heterocyclic ligands.
  • Preferred aromatic heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and
  • the metal chelate has greater than one polydentate ligand, the polydentate ligands may be the same or different.
  • Suitable polydentate ligands may be unsubstituted, or substituted by any of a large number of substituents known to the art.
  • Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl,
  • substituted aralkyl carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorous containing groups, and the carboxylate ester of N- hydroxysuccinimide.
  • the ruthenium or osmium may have one or more monodentate ligands, a wide variety of which are known to the art.
  • Suitable monodentate ligands include, for example, carbon monoxide, cyanides, isocyanides, halides, and aliphatic, aromatic and heterocyclic phosphines, amines, stibines, and arsines.
  • a more complete list of the ligands, e.g., monodentate and polydentate ligands, that can be used in the present invention are set forth in U.S. Patent Nos.
  • one or more of the ligands of the metal to be attached to additional chemical labels, such as, for example, radioactive isotopes, fluorescent compounds, or additional luminescent ruthenium- or osmium-containing centers.
  • the complementary single-stranded nucleic acid may be tagged with the preferred luminescent metal labels of the present invention via co-valent bonding to one or more of the polydentate ligands of the metal label through one more amide linkages.
  • This linkage may be oriented so that the nucleic acid is bonded directly either to the carbinol or to the nitrogen of the amide linkage.
  • These chemical moieties may be ionized.
  • the complementary single-stranded nucleic acid is unlabeled and hence,
  • double-stranded nucleic acid can be adsorbed to the film directly or can be created by first adsorbing single-stranded nucleic acid to the film and then hybridizing the adsorbed nucleic acid with its complementary sequence.
  • the film containing the adsorbed double-stranded nucleic acid is then immersed in a solution containing luminescent metal label or a solution suitable for promoting intercalation of the metal with the double-stranded nucleic acid.
  • suitable solutions include, but are not limited to water.
  • a nucleic acid in which the luminescent metal containing labels intercalates to produce nucleic acid—metal label chelates is then detected by inducing the metal label present in the chelates to emit electromagnetic radiation by creating an excited state of the metal species that will luminesce at wave lengths from about 200 nanometers to about 900 nanometers, at ambient temperatures.
  • Intercalation (or more generally, association) of the ECL labeled species with DNA depends upon the experimental conditions in which the label is partially inserted between the base pairs of DNA. It is considered “association” because of an electrostatic interaction between a positively-charged label and the negatively-charged phosphate groups on the DNA. The exact nature of the interaction of Ru(phen) 3 2+ with DNA is uncertain, but is believed to be intercalation.
  • the temperature must be below the melting point of ds-DNA, preferably about 25-30° C.
  • the pH is typically near 7, but within a range of about 5 to about 8.
  • the intercalation or association reaction must be given sufficient time to occur; about 30 to about 60 minutes, although times as short as 10 minutes also work.
  • the metal label is excited by exposing the nucleic acid-metal label chelates to electrochemical energy.
  • the potential at which the oxidation of the metal label will occur depends upon the exact structure of the metal label as well as factors such as the co-reactant utilized, the pH of the solution and the nature of the electrode used.
  • suitable co- reactants which, when incubated with the nucleic acid-metal label chelates in the presence of the electrochemical energy, will result in emission of the metal label intercalated with the nucleic acid, include tripropylamine (TPrA), oxalate or other organic acid such as pyruvate, lactate, malonate, tartrate and citrate.
  • This oxidation can also be performed chemically, with some strong oxidants such as PbO 2 or a Ce(IV) salt.
  • the electrochemiluminescent species may be measured by any suitable mechanism such as measurement of an electric current or emitted electromagnetic radiation.
  • the rate of energy inputted into the system can provide a measure of the luminescent species.
  • Suitable measurements include, for example, measurements of electric current when the luminescent species is generated electrochemically, the rate of reductant or oxidant
  • the luminescent species can be detected by measuring the emitted electromagnetic radiation. All of these measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time.
  • rate-based measurements would be by using photomultiplier tubes, photodiodes or
  • phototransistors to produce electric currents proportional in magnitude to the incident light intensity.
  • Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly.
  • chemiluminescent molecules such as luminol.
  • the latter labels produce a detectable event only once per molecule (or atom) of label, thereby limiting their detectability.
  • a MRC (Materials Research Corporation, Orangeburg, NY) Model 8620 sputtering system at 10 2 torr, with an RF power of 150 W and RF peak to peak voltage of 1.8 KV, was used to sputter gold (99.999%) on silicon wafers.
  • Polydeoxyadenylic acid Poly(dA)
  • polythymidylic acid poly(dT)
  • polydeoxycytidylic acid poly(dC)
  • CT calf thymus
  • ss-DNA can be carried out on a DNA synthesizer (e.g. Applied Biosystems, Model 381A) . See also L.J. McBride and M.H. Cruthers, Tetrahedron Letters, 24, 245 (1983).
  • a DNA synthesizer e.g. Applied Biosystems, Model 381A
  • the reagents used in the following examples include trichloroethylene (99.6%), 2-propanol (99.9%), tripropylamine (TPrA) (98%), Ru(bpy) 3 Cl 2 .6H 2 O, Ru(phen) 3 Cl 2 O, ethyl alcohol (200 proof), Al(NO 3 ) 3 .9H 2 O, K 2 Cr 2 O 7 , NaH 2 PO 4 and tris (hydroxymethyl) aminomethane and were used as received without purification.
  • Bisphosphonic acid H 2 O 3 P(CH 2 ) 4 PO 3 H 2 (C 4 BPA), and 4- mercaptobutylphosphonic acid (MBPA) were synthesized in accordance with the techniques taught by Mallouk et al,
  • experiments contained 0.13 M TPrA and 0.19 M phosphate buffer, prepared by dissolving TPrA into a NaH 2 PO 4 solution and
  • Deionized water from a Millipore Milli-Q (18 M ⁇ -cm) system was used to prepare all aqueous solutions and to rinse the electrode surface.
  • TEM samples were prepared by coating Au on a Formvar film on a #400 Cu grid with a vacum evaporator (Edwards 306), fabricating the Al 2 (C 4 BP) film on Au following the procedure described above and then immobilizing DNA on the Al 2 (C 4 BP) film.
  • a transmission electron microscope (JEOL 100CX) at 80 KV was used to image the Au substrate, the Al 2 (C 4 BP) film and the immobilized DNA.
  • Calf thymus ds-DNA was immobilized on the surface of an Al 2 (C 4 BP) film by immersing the film in a solution of DNA (1.9 mM in nucleotide phosphate, NP) for 4 h (Figs. 1 and 2). The film was then rinsed three times with 4-mL portions of deionized water and then immersed for 4 h in either an aqueous 0.56 mM Ru(phen) 3 Cl 2 solution or a 0.12 mM Ru(phen) 3 (Clo 4 ) 2 solution in MeCN. Ru(phen) 3 2+ associates with ds-DNA and can be detected through its electrogenerated chemiluminescence (ECL). Alternatively, the film could be soaked in a mixed ds- DNA (1.9 mM NP) and Ru(phen) 3 Cl 2 (0.12mM) solution for 4 h to produce the adsorbed layer.
  • ECL electrogenerated chemiluminescence
  • ECL was produced by scanning the potential of the electrode following film formation, DNA adsorption, and
  • QCM microbalance
  • the crystal frequency decreases as the Al 2 (C 4 BP) film forms and DNA and Ru(phen) 3 2+ are adsorbed on the surface, showing an increase of mass on the crystal during the
  • the mass change, ⁇ m can be related to the frequency change, ⁇ f, by the Sauerbrey equation: where F 0 is the fundamental frequency of the unloaded crystal (6 MHz), A is the electrode area (0.159 cm 2 ), p q is the density of quartz (2.65 g/cm 3 ) and ⁇ q is the shear modulus of quartz (2.95 x 10 11 dyne/cm 2 ). With these constants,
  • the electrode surface can be designed with immobilized DNA without adsorbing a detector molecule
  • Ru(phen) 3 2+ A ds-DNA on the surface can be detected by electrogenerated chemiluminescence of associated Ru(phen) 3 2+ .
  • Single-stranded DNA can also be immobilized on the Al 2 (C 4 BP) film surface and then hybridized with complementary DNA in solution with detection of the ds-DNA produced by ECL.
  • ⁇ -1 tagged ss-DNA i.e., labeled with Ru(bpy) 3 2+
  • the amount of immobilized DNA-Ru(bpy) 3 2+ on the surface was determined by ECL resulting from the oxidation of Ru(bpy) 3 2+ and TPrA in a solution.
  • Untagged ⁇ -1c ss-DNA was immobilized on an aluminum phosphate of the present invention.
  • Poly(dA) was immobilized on an aluminum phosphate film of the present invention by soaking the film in a
  • poly(dA) solution After the immobilization, poly(dT) was hybridized with poly(dA) to produce poly(dA) ⁇ poly(dT) ds-DNA on the surface by incubating the film in a poly(dT) solution at 70°C for 5 min and then cooled to the room temperature gradually (Fig. 4C).
  • a poly(dT) solution at 70°C for 5 min and then cooled to the room temperature gradually (Fig. 4C).
  • the Al 2 (C 4 BP) /poly (dA) ⁇ poly(dT) film was treated with a Ru(phen) 3 2+ solution.
  • the hybridized poly (dA) ⁇ poly (dT) -Ru(phen) 3 2+ on the surface was determined by ECL based on the oxidation of Ru(phen) 3 2+ and TPrA in the solution.
  • the aluminum phosphate film, prepared as described above was immersed in a 1.38 ⁇ M solution of ⁇ -1 30 bp ss-DNA (tagged with Ru(bpy) 3 2+ ) for -2 h. This was employed as a working electrode for an ECL experiment in a 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA. Cyclic voltammograms and emission transients were obtained by scanning the
  • Fig. 5A arise from the oxidation of TPrA, Ru(bpy) 3 2+ and the Au substrate and the reduction of the oxide of Au.
  • the ECL emission from the Al 2 (C 4 BP) / ⁇ -1 ss-DNA- Ru(bpy) 3 2+ electrode (Fig. 5B) demonstrates that the ⁇ -1 30 bp ss-DNA-Ru(bpy) 3 2+ was immobilized on the film.
  • the decay of the light intensity (I) as a function of time (t) was also investigated with the single-photon-counting system.
  • the decay of intensity with time suggests
  • the film was immersed in a 1.38 ⁇ M complementary strand ss-DNA (tagged with Ru(bpy) 3 2+ ) ( ⁇ -1 30 bp ss-DNA-Ru(bpy) 3 2+ ) solution.
  • the film in the solution was gradually heated to 60°C in water bath, incubated at 60°C for 5 min. and then slowly cooled to room-temperature, during which the ⁇ -1 ss-DNA-Ru(bpy) 3 2+ was hybridized with the
  • Al 2 (C 4 BP) / ⁇ -1 ss-DNA electrode is exposed to the ⁇ -1 ss-DNA- Ru(bpy) 3 2+ . It is preferred to cover all Al 3+ adsorption sites to avoid emission from the film/ ⁇ -1 ss-DNA/ ⁇ -1 ss-DNA- Ru(bpy) 3 2+ arising from some immobilization of ss-DNA- Ru(bpy) 3 2+ .
  • the aluminum phosphonate film prepared as described above, was immersed in a 21 ⁇ M poly(dA) solution for -4 h, then in a 0.24 mM Ru(phen) 3 2+ solution for -4 h.
  • the Al 2 (C 4 BP) /poly(dA) /Ru(phen) 3 2+ film was employed as a working electrode in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA, no ECL emission was observed (Fig. 8A). This is consistent with the lack of association of Ru(phen) 3 2+ with ss-DNA.
  • a film of poly(dA) was employed as a working electrode in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA.
  • FIG. 11A and 11B A further embodiment of the invention is shown in Figs. 11A and 11B.
  • a sensor surface having a multilayer film with bonding groups is provided with a complete set of
  • oligonucleotide probes using similar techniques described above for adsorbing ds-DNA and for SS-DNA. See Fig. 11A.
  • the sensor surface of Fig. HA is contacted with DNA to be
  • ss-DNA that make up a test sequence are attached to the surface of a chip to make an array.
  • the chip array is then exposed to the sample solution to be sequenced, with formation of ds-DNA at the appropriate location being recognized by the ECL approach.

Abstract

Single-strand DNA was immobilized on an electrode covered with an aluminum alkanebisphosphonate film by immersing it in an ss-DNA solution. The immobilized ss-DNA labeled with Ru(bpy)32+ was detected by monitoring the electrogenerated chemiluminescence (ECL) produced upon oxidation in a solution containing tri-n-propylamine. After immobilization of unlabeled ss-DNA, a complementary labeled strand DNA was hybridized to produce ds-DNA on the surface. The extent of DNA hybridization was determined by ECL of the labeled Ru(bpy)¿3?2+. Surface immobilized ds-DNA could also be detected by observing the ECL of intercalated Ru(phen)¿3?2+. Transmission electron microscopy (TEM) was employed to image the film and the immobilized DNA.

Description

Title of the Invention
BIOSENSOR FOR AND METHOD OF ELECTROGENERATED CHEMILUMINESCENT DETECTION OF NUCLEIC ACID ADSORBED TO A SOLID SURFACE Field Of Invention
The present invention relates to the diagnostic field, and especially nucleic acid diagnostics. In
particular, the present invention relates to a probe or sensor having a film containing metal centers, its preparation where a single-strand or double-strand nucleic acid sequence is immobilized thereon on, and its use in the subsequent
detection of the nucleic acid by labelling with luminescent metal chelates.
In addition to using the subject biosensor for nucleic acid diagnostics based on a surface designed modified electrical sensor, i.e., chips or electrode, immobilization and hybridization of nucleic acid such as DNA on a self- assembled thin film via surface reaction is also useful in studying molecular recognition of DNA. Background Of Invention
Nucleic acid diagnostics has become an important area in molecular biology and biotechnology studies, with applications to the determinations of disease and food contaminating organisms and in forensic and environmental investigations. The development of new DNA biosensors has led to the application of several detection techniques such as optical methods (e.g., luminescence, ellipsometry and pseudo- Brewster angle reflectometry), piezoelectric devices (e.g., SAW, QCM) , and electrochemical techniques (e.g., CV and SWV). Of particular interest are labels which can be made to
luminesce through photochemical, chemical, and electrochemical reaction schemes. In particular, electrochemiluminescent methods of determining the presence of labelled materials are preferred over other methods for many reasons. They are highly diagnostic of the presence of a particular label, sensitive, nonhazardous, inexpensive and can be used in a wide variety of applications. Suitable labels comprise
electrochemiluminescent compounds, including organic compounds and metal chelates.
For example, electrochemiluminescent ruthenium- and osmium-containing labels have been used in methods for detecting and quantifying analytes of interest in liquid media (U.S. Patent Nos. 5,310,687; 5,238,808; and 5,221,605). In addition, the application of electrogenerated chemiluminescence (ECL) measurements to the detection of solution phase DNA intercalated with ruthenium-containing labels has been described (Carter, M.T. et al. (1990) Bioconjugate Chem 2:257-263). However, reaction schemes that are viable in the solution phase are often not applicable in the solid phase. More importantly, the detection of solution phase analytes such as DNA has several drawbacks relative to detection of analytes absorbed to solid surfaces. The advantages for detecting DNA via solid phase techniques as opposed to solution techniques are: (1) more sensitive (detection of monolayer quantities); (2) easier to separate DNA from sample (avoid interferences); and (3) possibility of detection of several different DNA in single analysis, with localized probes, e.g., as in sequencing studies.
These luminescent systems are of increasing importance in diagnostics. For example, in U.S. Pat. No.
4,372,745, chemiluminescent labels are used in immunochemical applications where the labels are excited into a luminescent state by reaction of the label with H2O2 and an oxalate. In these systems, H2O2 oxidatively converts the oxalate into a high energy derivative, which then excites the label. It is expected, that in principle, the H2O2 and an oxalate reaction scheme should work with any luminescent material that is stable under the oxidizing conditions of the assay, and can be excited by the high energy oxalate derivative. Unfortunately, this very versatility is a major drawback of the 4,372,745 patent: lack of selectivity or specificity, i.e., typical biological fluids containing the analyte of interest also contain a large number of potentially luminescent substances that can cause high background levels of luminescence.
Thus a need exists for a solid phase system, e.g., a biosensor, and method that (1) provides the necessary
specificity absent systems that rely on the H2O2 and oxalate reaction scheme; and (2) do not depend on solution techniques. The present invention overcomes the limitations and drawbacks of the prior art.
Summary Of Invention
The present invention provides a biosensor and its use for electrogenerated chemiluminescent detection of nucleic acid absorbed to a solid surface via the use of ruthenium- and osmium-containing chemiluminescent labels.
An object of the present invention is to provide a film containing an aluminum (III) alkanebisphosphonate layer having metallic aluminum centers, i.e., ionic aluminum
Al(III) centers, for bonding to single-strand or double-strand DNA immobilized to said aluminum centers. The aluminum (III) alkanebisphosphonate can be provided as a biosensor having a coating of Al2(C4BP) to bond to SS-DNA or ds-DNA.
A further object of the present invention is to provide a biosensor in the form of chips or electrodes with adsorbed DNA that is labelled with a luminescent label, such as an osmium or ruthenium moiety.
A still further object of the present invention is to prepare a biosensor by treating a silicon wafer to form a chromium layer and juxtaposed gold layer, then contacting the layered wafer with an anchoring agent; and subsequently immersing the product in Al(NO3)3, bisphosphonic acid
(H2O3P(CH2)4PO3H2) and Al(NO3)3 aqueous solutions.
Another object of the present invention involves the detection of a nucleic acid by labelling with luminescent metal chelates. A further object of the present invention is to apply electrogenerated chemiluminescent techniques to a plurality, i.e., arrayed, oligonucleotide probes.
These and other objects will become more apparent from the following detailed description and drawings.
Brief Description Of The Drawinσs
Fig. 1 shows a schematic representation of the silicon electrode of the present invention containing ionic aluminum Al(III) sites. Fig. 2 shows immobilization of ds-DNA on a
Al2(C4BP) film and interaction of
Ru(phen)3 2+ with the ds-DNA.
Figs. 3A-3C show first (A), second (B), and third
(C) scans. ECL emission-potential transients at the Al2(C4BP) /DNA-Ru(phen)3 2+ electrode in 0.19 M phosphate buffer, pH 7, containing 0.13 M TPrA. (Scanning was halted and the solution stirred after each scan.) Scans were initiated at 0 V and were directed toward more positive potentials. Scan rate, 50 mV/s.
Figs. 4A-4C show schematic representations of
immobilization of ss-DNA tagged with Ru(bpy)3 2+ on the film (Fig. 4A);
immobilization of ss-DNA on the film and hybridization of complementary strand DNA tagged with Ru(bpy)3 2+ (Fig. 4B);
immobilization of poly(dA) on the film, hybridization of poly(dT), and then interaction of Ru(phen)3 2+ with the ds- DNA(poly(dA)●poly(dT)) where the ●
represents an ECL active species. Figures 5A-5C show a cyclic voltammogram (Fig. 5A);
an emission-potential transient of the Al2(C4BP)/λ-1 ss-DNA-Ru(bpy)3 2+ electrode in 0.19 M phosphate buffer/0.13 M TPrA, pH 7
(Fig. 5B); and an emission-potential transient of the Al2(C4BP)λ-1 ss-DNA in the same solution (Fig. 5C). The electrode used in the experiments shown in Figures 5A-5C was prepared as described in the specification with immersion in a 1.38 μM λ-1 ss-DNA-Ru(bpy)3 2+ or λ-1 ss-DNA solution for -4 h, respectively. In each case, the potential was scanned from 0 to 1.60 V at v = 50 mV/s.
Figure 6 shows an emission-time transient for the
Al2(C4BP)/λ-1 ss-DNA-Ru(bpy)3 2+ electrode in 0.19 M phosphate buffer/0.13 M TPrA, pH 7, when the potential was stepped from 0 to 1.5 V.
Figures 7A and 7B show ECL emission-potential
transients at the Al2(C4BP)/λ-1c ss-DNA/λ-1 ss-DNA-Ru(bpy)3 2+ electrode (Fig. 7A) and at the Al2(C4BP)/λ-l ss-DNA/λ-1 ss-DNA- Ru(bpy)3 2+ electrode (Fig. 7B) where both electrodes are immersed in 0.19 M phosphate buffer, pH 7, containing 0.13 M
TPrA and the potential was scanned from 0 to 1.60 at scan rate, 50 Mv/s.
Figures 8A and 8B show ECL emission-potential
transients at the
Al2(C4BP)/poly(dA)/poly(dT)/Ru (phen)3 2+ electrode (Fig. 8A) and at the
Al2(C4BP)/poly(dA)/Ru(phen)3 2+ electrode (Fig. 8B) where both electrodes are immersed in 0.19 M phosphate buffer, pH 7, containing 0.13 M TPrA, and the potential was scanned from 0 to 1.60 at scan rate, 50 mV/s.
Figures 9A-9C show TEM images of Au substrate coated on a Formvar film on a #400 Cu grid (Fig. 9A); the Al2(C4BP) film on the Au substrate
(Fig. 9B); immobilized calf thymus ds-DNA on the Al2(C4BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution for - 4 h (Fig. 9C).
Figures 10A-10C show TEM images of the Al2(C4BP)
film on Au substrate coated on a Formvar film (Fig. 10A); immobilized calf thymus ds-DNA on the Al2(C4BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution, for -4 h (Fig. 10B);
immobilized sonicated calf thymus ds-DNA on the Al2(C4BP) film, prepared by
immersing the film in a 1.65 mM [NP] of ds-DNA solution, sonicated for -6 h at room-temperature, for -4 h. (Fig. 10C) Figures 11A - 11B show sequencing via array
hybridization.
Detailed Description Of Invention
The present invention relates to a sensor and method of detecting nucleic acids using the sensor. The sensor can be a chip, electrode, or an appropriately modified surface for- adsorbing ss-DNA or ds-DNA. The nucleic acids detected by the method of the present invention include DNA, cDNA or any synthetic variant thereof. A nucleic acid as used throughout the specification and in the claims is meant DNA or any synthetic variant thereof.
Examples of DNAs detectable by the present method include chromosome DNA, plasmid DNA, viral DNA, bacterial DNA and recombinant DNA. The length of nucleic acid sequence capable of detection by the present method ranges from about 2.7 nm to about 200 nm. In a preferred embodiment, the nucleic acid sequence ranges from 8 base pair (bp)
nucleotides to 3,000 base pair nucleotides. In a most preferred embodiment ranges from about 30 bp nucleotides to 1,500 bp nucleotides.
In the present invention, the nucleic acid sequence to be detected may be of purified nucleic acid or may be present in a biological sample. Biological samples in which nucleic acids can be detected using the method of the present invention include but are not limited to biological fluids, e.g., serum, saliva, hair, skin, etc. Alternatively, the nucleic acid can be purified from a sample using methods known to those skilled in the art (Current Protocols in
Electrobiology (1994 ed. Ausubel, F.M. et al. John Wiley & Sons, Inc.)).
The aluminum (III) alkanebisphosphonate preferably used is a Al2(C4BP), also [Al2C4BP], film bearing biosensor and is prepared as follows. Silicon wafers were soaked in trichloroethylene for 30 min, rinsed twice with 2-propanol, rinsed with excess amount of deionized water, and then dried with a stream of dry nitrogen. The clean silicon wafers were primed with a 50 A chromium layer followed by deposition of a 2000 A gold layer. Chromium and gold targets (99.999%) were used to sputter the films onto the wafers in a MRC Model 8620 system at 10-2 torr. Other techniques, such as chemical vapor deposition (CVD) to apply the Au or Cr layers, can also be used.
The gold surface supported on the silicon wafers was cleaned with hot chromic acid (saturated K2Cr2O7 in 90% H2SO4) for -10 s and then rinsed with copious amounts of water. This process was repeated until the surface contact angle with water was less than 15°. The clean Au surface was then immediately soaked in an anchoring agent, 0.5 mM 4- mercaptobutylphosphonic acid (MBPA) solution in absolute ethanol for -24 h. See Fig. 1. The phosphoric acid
terminated surface was then thoroughly rinsed with the
ethanol, dried with a stream of N2 and then immersed
alternately in 5 mM A1(NO3)3, 5 mM bisphosphonic acid
(H203P(CH2)4P03H2) and 5 mM A1(NO3)3 aqueous solution, taking -4 h for each immersion, with washing with water between each step. Although the preferred embodiment contemplates the use of Al centers, other metal centers, such as, lanthanum (La) and zirconium (Zr) are also contemplated. In addition, although a C4 specie was utilized in producing the alkanebisphosphonate film, other chain links, C2-C16 may be utilized, which result, in adequate spacing of the aluminum ions on the surface of the film to permit contact with the phosphates of the DNA
backbone. In other words, the "spacer" may range from 2 to 16 carbons in length.
The sensor described above is used by:
a) adsorbing a nucleic acid onto a film containing metal centers;
b) reacting nucleic acid adsorbed to said film with a luminescent metal label; and
c) detecting the nucleic acid metal label chelates formed in step b) via electrogenerated chemiluminescence of said chelates. In step (a), the film to which the nucleic acid is adsorbed should contain metal ions which are suitably spaced on the surface of the film to allow interaction of the metal with the phosphate backbone of the nucleic acid sequence.
Examples of metal centers suitable for use in binding to nucleic acid phosphate groups are aluminum, lanthanum, and zirconium. In a preferred embodiment, the film contains an aluminum Al (III) metal center.
The nucleic acid adsorbed to the film in step (a) of the method of the present invention may be either double- stranded or single-stranded. When a single-stranded nucleic acid is adsorbed to the film, the adsorbed single-stranded nucleic acid is then hybridized to a complementary single- stranded nucleic acid sequence. Conditions of hybridization are utilized which promote base pairing between the single- stranded DNA adsorbed to the film in its complementary sequence. Factors influencing hybridization between nucleic acid sequences are known to those skilled in the art and include salt concentration of the hybridization solution, hybridization temperature and stringency of post-hybridization washes. In addition, the length of hybridization may also be controlled to optimize binding. Satiable buffers in which to carry out the hybridization reaction include 5mM Tris buffer, pH 7 containing 50 mM NaCl.
The complementary single-stranded nucleic acid sequence hybridized with the nucleic acid adsorbed to the film may be unlabeled or labeled with a luminescent metal label. Suitable luminescent labels include ruthenium- and osmium- containing labels where ruthenium or osmium are bound to at least one polydentate ligand. If the metal has greater than one polydentate ligand, the polydentate ligands may be the same or different. (Other known ECL active labels can also be utilized that emit at different wave lengths such as organic ECL labels, e.g. sulfonated-9,10-diphenylanthracene.)
Polydentate ligands of either ruthenium or osmium include aromatic and aliphatic ligands. Suitable aromatic polydentate ligands include aromatic heterocyclic ligands. Preferred aromatic heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and
phenanthrolyl. If the metal chelate has greater than one polydentate ligand, the polydentate ligands may be the same or different.
Suitable polydentate ligands may be unsubstituted, or substituted by any of a large number of substituents known to the art. Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl,
substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorous containing groups, and the carboxylate ester of N- hydroxysuccinimide.
The ruthenium or osmium may have one or more monodentate ligands, a wide variety of which are known to the art. Suitable monodentate ligands include, for example, carbon monoxide, cyanides, isocyanides, halides, and aliphatic, aromatic and heterocyclic phosphines, amines, stibines, and arsines. A more complete list of the ligands, e.g., monodentate and polydentate ligands, that can be used in the present invention are set forth in U.S. Patent Nos.
5,310,687, 5,238,808 and 5,221,605, the subject matter of which are incorporated herein by reference.
It is also within the scope of this invention for one or more of the ligands of the metal to be attached to additional chemical labels, such as, for example, radioactive isotopes, fluorescent compounds, or additional luminescent ruthenium- or osmium-containing centers.
The complementary single-stranded nucleic acid may be tagged with the preferred luminescent metal labels of the present invention via co-valent bonding to one or more of the polydentate ligands of the metal label through one more amide linkages. This linkage may be oriented so that the nucleic acid is bonded directly either to the carbinol or to the nitrogen of the amide linkage. These chemical moieties may be ionized. A more elaborate description of methods for
attaching a luminescent ruthenium-containing or osmium- containing label to amino groups of biological substances such as nucleic acid is provided in U.S. Patent No. 5,221,605 incorporated by reference.
In an alternative embodiment, the complementary single-stranded nucleic acid is unlabeled and hence,
hybridization to a single-stranded nucleic acid adsorbed to a film results in generation of unlabeled double-stranded nucleic acid adsorbed to the film. Thus, double-stranded nucleic acid can be adsorbed to the film directly or can be created by first adsorbing single-stranded nucleic acid to the film and then hybridizing the adsorbed nucleic acid with its complementary sequence. In either case, the film containing the adsorbed double-stranded nucleic acid is then immersed in a solution containing luminescent metal label or a solution suitable for promoting intercalation of the metal with the double-stranded nucleic acid. Examples of suitable solutions include, but are not limited to water.
A nucleic acid in which the luminescent metal containing labels intercalates to produce nucleic acid—metal label chelates is then detected by inducing the metal label present in the chelates to emit electromagnetic radiation by creating an excited state of the metal species that will luminesce at wave lengths from about 200 nanometers to about 900 nanometers, at ambient temperatures. Intercalation (or more generally, association) of the ECL labeled species with DNA depends upon the experimental conditions in which the label is partially inserted between the base pairs of DNA. It is considered "association" because of an electrostatic interaction between a positively-charged label and the negatively-charged phosphate groups on the DNA. The exact nature of the interaction of Ru(phen)3 2+ with DNA is uncertain, but is believed to be intercalation. The temperature must be below the melting point of ds-DNA, preferably about 25-30° C. The pH is typically near 7, but within a range of about 5 to about 8. The intercalation or association reaction must be given sufficient time to occur; about 30 to about 60 minutes, although times as short as 10 minutes also work.
In one embodiment of the present invention, the metal label is excited by exposing the nucleic acid-metal label chelates to electrochemical energy. The potential at which the oxidation of the metal label will occur depends upon the exact structure of the metal label as well as factors such as the co-reactant utilized, the pH of the solution and the nature of the electrode used. Examples of suitable co- reactants which, when incubated with the nucleic acid-metal label chelates in the presence of the electrochemical energy, will result in emission of the metal label intercalated with the nucleic acid, include tripropylamine (TPrA), oxalate or other organic acid such as pyruvate, lactate, malonate, tartrate and citrate. This oxidation can also be performed chemically, with some strong oxidants such as PbO2 or a Ce(IV) salt.
Those of ordinary skill in the art recognize how to determine the optimal potential and emission wave length of an electrochemiluminescent system. The electrochemiluminescent species may be measured by any suitable mechanism such as measurement of an electric current or emitted electromagnetic radiation. For example, the rate of energy inputted into the system can provide a measure of the luminescent species.
Suitable measurements include, for example, measurements of electric current when the luminescent species is generated electrochemically, the rate of reductant or oxidant
utilization when the luminescent species is generated
chemically or the absorption of electromagnetic energy in photoluminescent techniques. In addition, of course, the luminescent species can be detected by measuring the emitted electromagnetic radiation. All of these measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time. An example of rate-based measurements would be by using photomultiplier tubes, photodiodes or
phototransistors to produce electric currents proportional in magnitude to the incident light intensity. Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly.
All of these luminescence-based methods entail repeated luminescence by the ruthenium-containing compound. The repetitive nature of the detectable event distinguishes these labels from radioactive isotopes or bound
chemiluminescent molecules such as luminol. The latter labels produce a detectable event only once per molecule (or atom) of label, thereby limiting their detectability.
The following examples illustrate various aspects of the invention but are in no way intended to limit the scope thereof. Analysis was performed in a Plexiglas cell designed for ECL and electrochemical studies using the film of the present invention, a gold surface supported on the silicon wafer containing metallic sites, e.g., Al. A saturated calomel reference electrode (SCE) and a platinum wire counter electrode were used for all measurements. The electrochemical measurements coupled with ECL experiments were carried out with a Model 175 universal programmer, a Model 173
potentiostat (Princeton Applied Research, PAR, Princeton, NJ), and an Ominigraphic 2000 X-Y recorder (Houston Instruments, Houston, TX). The ECL emission was detected by a Model C123 single-photon-counting system (Hamamatsu Corp., Bridgewater, NJ) utilizing a Hamamatsu R928P PMT, cooled to -20°C in a Model TE 308 TSRF cooler controller (Products for Research Inc., Danvers, MA). The meter output was fed into the y-axis of the x-y recorder, and the signal from the potentiostat was fed into the x-axis to afford ECL intensity versus bias potential display. Solution analysis by ECL was carried out with a QPCR analyzer (Perkin-Elmer, Norwalk, CT).
A MRC (Materials Research Corporation, Orangeburg, NY) Model 8620 sputtering system at 102 torr, with an RF power of 150 W and RF peak to peak voltage of 1.8 KV, was used to sputter gold (99.999%) on silicon wafers.
Polydeoxyadenylic acid (Poly(dA)), polythymidylic acid (poly(dT), polydeoxycytidylic acid (poly(dC)) and calf thymus (CT) ss-DNA and ds-DNA were obtained from Sigma
Chemical Co. (St. Louis, MO) and were used without additional purification. The ss-DNA samples, λ-1 DNA
(5'GAAAATGTGCTGACCGGACATGAAAATGAG3'), (Seq. ID. No. 1) λ DNA tagged with Ru(bpy)3 2+(5'Ru(bpy)3 2+-
GAAAATGTGCTGACCGGACATGAAAATGAG3'), (Seq. ID. No. 2) and a complementary strand λ-lc DNA
(5'CTCATTTTCATGTCCGGTCAGCACATTTTC3') , were obtained from
Perkin-Elmer and diluted with a 5 mM tris buffer containing 50 mM NaCl(pH 7). Synthesis of ss-DNA can be carried out on a DNA synthesizer (e.g. Applied Biosystems, Model 381A) . See also L.J. McBride and M.H. Cruthers, Tetrahedron Letters, 24, 245 (1983).
The reagents used in the following examples include trichloroethylene (99.6%), 2-propanol (99.9%), tripropylamine (TPrA) (98%), Ru(bpy)3Cl2.6H2O, Ru(phen)3Cl2O, ethyl alcohol (200 proof), Al(NO3)3.9H2O, K2Cr2O7, NaH2PO4 and tris (hydroxymethyl) aminomethane and were used as received without purification. Bisphosphonic acid H2O3P(CH2)4PO3H2 (C4BPA), and 4- mercaptobutylphosphonic acid (MBPA) were synthesized in accordance with the techniques taught by Mallouk et al,
J.A.C.S., 115, 11855 (1993). The assay buffer for ECL
experiments contained 0.13 M TPrA and 0.19 M phosphate buffer, prepared by dissolving TPrA into a NaH2PO4 solution and
adjusting the pH to 7 with 1 M NaOH.
Deionized water from a Millipore Milli-Q (18 MΩ-cm) system was used to prepare all aqueous solutions and to rinse the electrode surface.
TEM Sample Preparation.
TEM samples were prepared by coating Au on a Formvar film on a #400 Cu grid with a vacum evaporator (Edwards 306), fabricating the Al2(C4BP) film on Au following the procedure described above and then immobilizing DNA on the Al2(C4BP) film. A transmission electron microscope (JEOL 100CX) at 80 KV was used to image the Au substrate, the Al2(C4BP) film and the immobilized DNA.
Example 1
Electrogenerated Chemiluminescent Detection of lmmobilized ds-DNA using A Ruthenium Label.
Calf thymus ds-DNA was immobilized on the surface of an Al2(C4BP) film by immersing the film in a solution of DNA (1.9 mM in nucleotide phosphate, NP) for 4 h (Figs. 1 and 2). The film was then rinsed three times with 4-mL portions of deionized water and then immersed for 4 h in either an aqueous 0.56 mM Ru(phen)3Cl2 solution or a 0.12 mM Ru(phen)3(Clo4)2 solution in MeCN. Ru(phen)3 2+ associates with ds-DNA and can be detected through its electrogenerated chemiluminescence (ECL). Alternatively, the film could be soaked in a mixed ds- DNA (1.9 mM NP) and Ru(phen)3Cl2 (0.12mM) solution for 4 h to produce the adsorbed layer.
ECL was produced by scanning the potential of the electrode following film formation, DNA adsorption, and
Ru(phen)3 2+ association, from 0 to 1.6 V vs. a saturated calomel electrode (SCE) while it was immersed in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M tri-n- propylamine (TPrA). Typical ECL transients, detected with a single-photon-counting apparatus, are shown in Figures 3A-3C. Emission arises from the energetic electron-transfer reaction between electrogenerated Ru(phen)3 3+ and an intermediate in the oxidation of TPrA:
DNA-Ru(phen)3 2+ (ads) - e → DNA-Ru(phen)3 3+ [1]
CH3CH2CH2-N-Pr2 - e - CH3CH*,CH:NPr-,-f [2]
CH3CH2CH2NPr2 + → CH3CH2CHNPr2 + H+ [3] DNA-Ru(phen)3 3+ + CH3CH2CHNPr2→DNA-Ru(phen)3 2+●+CH3CH2CHNPr2 + [4] DNA-Ru(phen)3 2+●→ DNA-Ru(phen)3 2+ + hυ [5]
The emission intensity decreased on a second scan and none was seen on a third, suggesting loss of Ru(phen)3 3+ from the film and diffusion into the bulk solution.
In a control experiment, an electrode with a film of Al2(C4BP) that had not been treated with DNA was soaked for 4 h in either an aqueous 0.56 mM Ru(phen)3 2+ or a 0.12 mM
Ru(phen)3 2+ in MeCN solution and then rinsed with MeCN and water. This electrode showed no ECL emission upon potential sweep in the same TPrA solution described above, demonstrating the adsorption of Ru(phen)3 2+ on the Al2(C4BP) film does not occur. The ability to generate Ru(phen)3 3+ electrochemically in this ECL experiment demonstrates that the Al2(C4BP) film and the DNA layer do not prevent heterogeneous electron-transfer reactions.
To obtain further evidence for Al, (C4BP) film formation and DNA immobilization, experiments were undertaken with a gold-coated quartz crystal and a quartz crystal
microbalance (QCM). The gold was repeatedly treated with hot chromic acid and then rinsed with water and EtOH until the surface was hydrophilic, as indicated by contact angle
measurements. The crystal frequency was then measured in air during different stages of Al2(C4BP) film formation, after DNA adsorption, and after Ru(phen)3 2+ association. The film was rinsed after each step with deionized water and dried in a stream of N2 before measurement of the frequency. Results are shown in Table 1.
Figure imgf000025_0001
a Immersions were sequential in order given from top to bottom; bare surface was gold; bare crystal frequency, 6.011329 MHz. b 0.5 mM MBPA in EtOH for - 24 h.
c 5 mM aq. Al(NO3)3 for - 4 h.
d 5 mM phosphoric acid for 4 h.
e Calf thymus DNA (3.8 mM NP) for 4 h.
f 0.24 mM Ru(phen)3 2+ in MeCN for 4 h.
g The variation and drift of the signal over the series of measurements was about ± 1 Hz.
h Assuming roughness factor for gold of 2 (total surface area, 0.6 cm2). For comparison, for a close-packed monolayer of
MBPA, T = 0.6 x 10-9 mol/cm2.
i Assuming an Al(H2O)3 3+ until adsorbed.
j Corresponding to moles of nucleotide phosphate (NP) per cm2.
Clearly, the crystal frequency decreases as the Al2(C4BP) film forms and DNA and Ru(phen)3 2+ are adsorbed on the surface, showing an increase of mass on the crystal during the
different stages. The mass change, Δm, can be related to the frequency change, Δf, by the Sauerbrey equation:
Figure imgf000026_0001
where F0 is the fundamental frequency of the unloaded crystal (6 MHz), A is the electrode area (0.159 cm2), pq is the density of quartz (2.65 g/cm3) and μq is the shear modulus of quartz (2.95 x 1011 dyne/cm2). With these constants,
Δm (ng) = -1.95 Δf (Hz)
The mass changes calculated in this way are also given in Table l. These can be converted to approximate surface concentrations, r, assuming a roughness factor of 2 (i.e., total surface area of both sides of the quartz crystal of 0.6 cm2) . ECL could also be detected from both gold surfaces of the quartz crystal, when used as a substrate for Al2(C4BP) film formation, DNA adsorption and Ru(phen)3 2+ association and then scanned in the TPrA solution.
The electrode surface can be designed with immobilized DNA without adsorbing a detector molecule,
Ru(phen)3 2+. A ds-DNA on the surface can be detected by electrogenerated chemiluminescence of associated Ru(phen)3 2+. Single-stranded DNA can also be immobilized on the Al2(C4BP) film surface and then hybridized with complementary DNA in solution with detection of the ds-DNA produced by ECL. Example 2
Single-strand DNA immobilization and hybridization. λ-1 tagged ss-DNA (i.e., labeled with Ru(bpy)3 2+) was immobilized on an aluminum phosphate film of the present invention by immersing the film in the DNA solution (Fig. 4A). The amount of immobilized DNA-Ru(bpy)3 2+ on the surface was determined by ECL resulting from the oxidation of Ru(bpy)3 2+ and TPrA in a solution.
Untagged λ-1c ss-DNA was immobilized on an aluminum phosphate of the present invention. The λ-1c ss-DNA
containing film was incubated in a complementary strand λ-1 tagged ss-DNA solution at 60°C for 5 min and then cooled to room temperature gradually; during this cooling the ss-DNA hybridized with the complementary strand DNA (Fig. 4B). The hybridized DNA-Ru(bpy)3 2+ on the film was detected by ECL as described above.
Poly(dA) was immobilized on an aluminum phosphate film of the present invention by soaking the film in a
poly(dA) solution. After the immobilization, poly(dT) was hybridized with poly(dA) to produce poly(dA)●poly(dT) ds-DNA on the surface by incubating the film in a poly(dT) solution at 70°C for 5 min and then cooled to the room temperature gradually (Fig. 4C). To intercalate Ru(phen)3 2+ into the ds- DNA (poly (dA)●poly (dT)), the Al2(C4BP) /poly (dA)●poly(dT) film was treated with a Ru(phen)3 2+ solution. The hybridized poly (dA)●poly (dT) -Ru(phen)3 2+ on the surface was determined by ECL based on the oxidation of Ru(phen)3 2+ and TPrA in the solution.
Example 3
lmmobilization and Detection of 30 bp ss-DNA.
lmmobilized On Aluminum Phosphate Film.
The aluminum phosphate film, prepared as described above was immersed in a 1.38 μM solution of λ-1 30 bp ss-DNA (tagged with Ru(bpy)3 2+) for -2 h. This was employed as a working electrode for an ECL experiment in a 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA. Cyclic voltammograms and emission transients were obtained by scanning the
potential of the electrode from 0 to 1.6 V vs, a saturated calomel electrode (SCE). A representative voltammogram and emission detected with a single-photon-counting system are shown in Figures 5A-5C. The broad oxidation was at - 1.2 V and a small reduction wave at -0.35 V observed in the
voltammogram (Fig. 5A) arise from the oxidation of TPrA, Ru(bpy)3 2+ and the Au substrate and the reduction of the oxide of Au. The ECL emission from the Al2(C4BP) /λ-1 ss-DNA- Ru(bpy)3 2+ electrode (Fig. 5B) demonstrates that the λ-1 30 bp ss-DNA-Ru(bpy)3 2+ was immobilized on the film. The decay of the light intensity (I) as a function of time (t) was also investigated with the single-photon-counting system. The light intensity detected by the photomultiplier tube, when the potential was stepped from 0 to 1.50 V, decreased with time (Fig. 6). The decay of intensity with time suggests
desorption of ss-DNA-Ru(bpy)3 2+ from the electrode surface or irreversible decomposition of the emitter. Emission results from the energetic electron-transfer reaction between
electrogenerated Ru(bpy)3 3+ and an intermediate in the
oxidation of TPrA: DNA-Ru(bpy)3 2+ (ads) → DNA-Ru(bpy)3 3+ + e' [6]
CH3CH2CH2NPr2 - e → CH3CH2CH2NPr2 + [7]
CH3CH2CH2NPr2 + → CH3CH2CHNPr2 + H+ [8]
DNA-Ru(bpy)3 3++CH3CH2CHNPr2 → DNA-Ru(bpy) 3 2+*+CH3CH2CHNPr2 + [9]
DNA-Ru(bpy)3 2+*→ DNA-Ru(bpy)3 2+ + hυ [10] No ECL emission was observed from a film prepared by immersing it in solution of unlabeled ss-DNA: 1.38 μM λ-1 30 bp ss-DNA or a 0.37 μM λ-1c 30 bp ss-DNA solution (Fig. 5C).
A control experiment with the aluminum phosphate film immersed in a 304 nM Ru(bpy)3 2+ solution for - 4 h shows a negligible ECL signal, indicating that Ru(bpy)3 2+ does not adsorb on the film and oxidize.
Example 4
Detection of 30 bp ss-DNA Hybridized to
Complementary SS-DNA Tagged With A Ruthewium Label.
After the immobilization of unlabeled λ-1c 30 bp ss-
DNA on the Al2(C4BP) film, the film was immersed in a 1.38 μM complementary strand ss-DNA (tagged with Ru(bpy)3 2+) (λ-1 30 bp ss-DNA-Ru(bpy)3 2+) solution. The film in the solution was gradually heated to 60°C in water bath, incubated at 60°C for 5 min. and then slowly cooled to room-temperature, during which the λ-1 ss-DNA-Ru(bpy)3 2+ was hybridized with the
complementary strand λ-lc ss-DNA on the surface as illustrated in Fig. 4B. The film with hybridized DNA was employed as the working electrode in an ECL cell as described above. The ECL emission from the film was observed as shown in Fig. 7A.
However, when λ-1 ss-DNA, rather than λ-1c ss-DNA, was immobilized on the film and followed by the same hybridization procedure as described above by incubating the film in the λ-1 ss-DNA-Ru(bpy)3 2+ solution, heating to 60°C, and then cooling to room-temperature, no obvious ECL emission was evident as shown in Fig. 7B. This demonstrates that the ECL emission in Fig. 7A arises from the hybridization of immobilized λ-lc ss- DNA with λ-1 ss-DNA-Ru(bpy)3 2+ in the solution. The emission again results from the oxidation of Ru(bpy)3 2+-tagged
hybridized ss-DNA and TPrA in the solution as described by Eqs. [6] - [10]. In this experiment the Al2(C4BP) film should be incubated in the λ-1 ss-DNA solution for a sufficiently long time (at least 4 h) to cover all possible Al (III) binding sites on the film with the λ-1 ss-DNA before the
Al2(C4BP) /λ-1 ss-DNA electrode is exposed to the λ-1 ss-DNA- Ru(bpy)3 2+. It is preferred to cover all Al3+ adsorption sites to avoid emission from the film/λ-1 ss-DNA/λ-1 ss-DNA- Ru(bpy)3 2+ arising from some immobilization of ss-DNA- Ru(bpy)3 2+. Example 5
Detection of poly(dA) Hybridized to poly(dT) using a Ruthenium Label.
The aluminum phosphonate film, prepared as described above, was immersed in a 21 μM poly(dA) solution for -4 h, then in a 0.24 mM Ru(phen)3 2+ solution for -4 h. When the Al2(C4BP) /poly(dA) /Ru(phen)3 2+ film was employed as a working electrode in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA, no ECL emission was observed (Fig. 8A). This is consistent with the lack of association of Ru(phen)3 2+ with ss-DNA. However, a film of poly(dA)
hybridized with only poly(dT) to form ds-DNA did produce ECL. This film, formed by immersion in the poly(dA) solution, was incubated in a 38 μM poly(dT) solution (gradually heated to 70°C in a water bath, incubated at 70°C for 5 min and then slowly cooled to room temperature). It was then treated with a 0.24 mM Ru(phen)3 2+ aqueous solution and used as a working electrode in the TPrA-containing phosphate buffer for ECL investigation. ECL emission was observed as shown in a representative emission transient (Fig. 8B), demonstrating that poly(dT) in the solution hybridized with the poly(dA) on the surface to produce a ds-DNA [poly(dA)●poly(dT] and
Ru(phen)3 2+ intercalated with the ds-DNA as shown in Fig. 4c.
These examples show that Ru(phen)3 2+ only
intercalates with ds-DNA [poly (dA)●poly (dT], but not with ss- DNA (poly(dA)). Intercalation of Ru(phen)3 2+ with ss-DNA and ds-DNA, ECL emission was measured from a 43 nM Ru(phen)3 2+ solution, a 43 nM Ru(phen)3 2+ containing 57 μM nucleotide phosphate ([NP]) of calf thymus ss-DNA and a 43 nM Ru(phen)3 2+ containing 33 μM [NP] of calf thymus ds-DNA with a QPCR analyzer. Results are given in Table 2,
Figure imgf000033_0001
indicating that the ECL emission decreased after ds-DNA was added to the Ru(phen)3 2+ solution. A negligible change, however, in the ECL signal was shown when ss-DNA was added, further demonstrating that Ru(phen)3 2+ only intercalates with ds-DNA, but not with ss-DNA.
A control experiment in which a film, after the immobilization of poly(dA), was incubated in a 21 μM poly(dA) or a 46 μM poly(dC) solution instead of poly(dT) (70°C for 5 min then cooled to room-temperature) and then treated with Ru(phen)3 2+ for -2 h produces no ECL emission. This indicates that the Al2(C4BP) /poly(dA) electrode can distinguish a complementary strand of poly(dT) DNA from non-complementary ones. Example 6
TEM Images of the film and calf thymus ds-DNA.
Samples, prepared by coating Au on a Formvar film on a #400 Cu grid with a vacuum evaporator, fabricating the aluminum phosphate film on the Au as described above, and then immobilizing DNA on the Al2(C4BP) film by immersing the film in a 1.65 mM [NP] of calf thymus ds-DNA for 4 h, were imaged with a transmission electron microscope (TEM) at 80 KV. As shown in Figs. 9A-9C the featureless Au substrate (Fig. 9A) shows formation of crystalline islands of A12(C4BP) film (Fig. 9B) and clumps of DNA (Fig. 9C). The film (Fig. 10A) was then treated with either 1.65 mM [NP] calf thymus ds-DNA (Fig. 10B) or an identical solution of ds-DNA that had been subjected to sonication for 6 h (Fig. 10C). The results indicate that smaller clumps of DNA are adsorbed on the film after
sonication.
A further embodiment of the invention is shown in Figs. 11A and 11B. A sensor surface having a multilayer film with bonding groups is provided with a complete set of
oligonucleotide probes using similar techniques described above for adsorbing ds-DNA and for SS-DNA. See Fig. 11A. The sensor surface of Fig. HA is contacted with DNA to be
sequenced. The above disclosed ECL procedures are then used to recognize zones with a complementary sequence. (Fig. 11B).
When chips are used, different types of ss-DNA that make up a test sequence are attached to the surface of a chip to make an array. The chip array is then exposed to the sample solution to be sequenced, with formation of ds-DNA at the appropriate location being recognized by the ECL approach.
Although the invention has been described in
conjunction with the specific embodiments, it is evident that many alternatives and variations will be apparent to those skilled in the art in light of the foregoing description.
Accordingly, the invention is intended to embrace all of the alternatives and variations that fall within the spirit and scope of the appended claims.
Figure imgf000036_0001
Figure imgf000037_0001
Figure imgf000038_0001
Figure imgf000039_0001

Claims

1. A method of detecting nucleic acids comprising:
a. forming a sensor surface bearing a film having metallic centers;
b. adsorbing at least one nucleic acid onto to said metal centers;
c. reacting nucleic acid adsorbed to said film with a luminescent metal label; and
d. detecting the nucleic acid metal label chelates formed in step (c) via electrogenerated chemiluminescence of said chelates.
2. The method of claim 1, wherein the nucleic acid of step (b) is double-stranded.
3. The method of claim 1, wherein the nucleic acid of step (b) is single-stranded.
4. The method of claim 3, wherein step (c) further comprises binding the single-stranded nucleic acid adsorbed to the film, to a complementary single-stranded nucleic acid sequence.
5. The method of claim 1, wherein said electrogenerated chemiluminescence arises from a reaction of an
electrogenerated metal label in the nucleic acid -metal label chelate and a suitable coreactant.
6. The method of claim 5, wherein said electrogenerated metal label is produced via emission from the sensor which is an electrode.
7. A method of detecting nucleic acids comprising:
a. forming an electrode by adsorbing at least one nucleic acid onto said electrode;
b. reacting nucleic acid adsorbed to said electrode with a luminescent label; and
c. detecting the nucleic acid label formed in step (b) via electrogenerated chemiluminescence.
8. The method of claim 7, wherein the nucleic acid of step (b) is double-stranded.
9. The method of claim 7, wherein the nucleic acid of step (b) is single-stranded.
10. The method of claim 8, wherein step (c) further comprises binding the single-stranded nucleic acid adsorbed to the electrode, to a complementary single-stranded nucleic acid sequence.
11. The method of claim 7, wherein said electrogenerated chemiluminescence arises from a reaction of an electrogenerated metal label in the nucleic acid - metal label chelate and a suitable coreactant.
12. The method of claim 11, wherein said
electrogenerated metal label is produced via emission from the electrode.
13. An aluminum alkanebisphosphonate biosensor
comprising:
a substrate and a first metallic layer; and an aluminum alkanebisphosphonate layer forming (Al) metallic centers.
14. A biosensor according to claim 13 , wherein said biosensor further includes single-strand DNA immobilized to said aluminum centers.
15. A biosensor according to claim 14, wherein said DNA is labelled with and an osmium or ruthenium moiety.
16. A biosensor according to claim 13, wherein said biosensor further includes double-strand DNA immobilized to said aluminum centers.
17. A biosensor according to claim 16, wherein said DNA is labelled with an osmium or ruthenium moiety.
18. A method of preparing a biosensor for nucleic acid, comprising:
a) treating a silicon wafer to form a chromium layer and juxtaposed gold layer;
b) contacting said layered wafer with an anchoring agent; and
c) immersing the product of step b) alternately in Al(NO3)3, bisphosphonic (H2O3P(CH2)4PO3H2) and Al(NO3)3 aqueous solutions.
19. A biosensor comprising:
an electrode substrate, adsorbed ss-DNA or ds-DNA immobilized on said electrode, and a detectable label on said ss-DNA or ds-DNA.
20. A biosensor according to claim 19, wherein said DNA is labelled with an osmium or ruthenium moiety or a
luminescent label.
PCT/US1995/010630 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface WO1996006946A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP8508822A JPH10509025A (en) 1994-08-26 1995-08-25 Biosensor and method for electrogenerated chemiluminescent detection of nucleic acids adsorbed on solid surface
EP95930881A EP0777741A4 (en) 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface
AU34103/95A AU703344B2 (en) 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29663094A 1994-08-26 1994-08-26
US08/296,630 1994-08-26

Publications (1)

Publication Number Publication Date
WO1996006946A1 true WO1996006946A1 (en) 1996-03-07

Family

ID=23142843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/010630 WO1996006946A1 (en) 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface

Country Status (5)

Country Link
EP (1) EP0777741A4 (en)
JP (1) JPH10509025A (en)
AU (1) AU703344B2 (en)
CA (1) CA2198489A1 (en)
WO (1) WO1996006946A1 (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755458A1 (en) * 1995-02-09 1997-01-29 Igen, Inc. Electrogenerated chemiluminescence labels for analysis and/or referencing
WO1998045475A1 (en) * 1997-04-09 1998-10-15 Cis Bio International System for detecting nucleic acid hybridisation, preparation method and application thereof
US6066448A (en) * 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6140045A (en) * 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
US6207369B1 (en) 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
WO2001042508A2 (en) * 1999-12-09 2001-06-14 Motorola, Inc. Methods and compositions relating to electrical detection of nucleic acid reactions
US6518024B2 (en) 1999-12-13 2003-02-11 Motorola, Inc. Electrochemical detection of single base extension
EP1322787A1 (en) * 2000-10-05 2003-07-02 Virginia Tech Intellectual Properties, Inc. Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US6824669B1 (en) 2000-02-17 2004-11-30 Motorola, Inc. Protein and peptide sensors using electrical detection methods
US6977151B2 (en) 1996-11-05 2005-12-20 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US7138121B2 (en) 2003-01-23 2006-11-21 Spangler Brenda D Biosensors utilizing dendrimer-immobilized ligands and there use thereof
US7361470B2 (en) 2003-05-13 2008-04-22 Trustees Of Boston College Electrocatalytic nucleic acid hybridization detection
WO2006076047A3 (en) * 2004-08-06 2009-04-09 Trustees Boston College Electrocatalytic nucleic acid hybridization detection
EP2186910A2 (en) 1997-12-23 2010-05-19 Meso Scale Technologies LLC Methods and compositions for improved luminescence assays using microparticles
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US8888969B2 (en) 2008-09-02 2014-11-18 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biosensing devices incorporating the same
US9151746B2 (en) 1999-04-21 2015-10-06 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9580742B2 (en) 2011-03-10 2017-02-28 Shana O. Kelley Diagnostic and sample preparation devices and methods
WO2017153336A1 (en) 2016-03-07 2017-09-14 F. Hoffmann-La Roche Ag Detection of anti-p53 antibodies
WO2018141768A1 (en) 2017-02-02 2018-08-09 Roche Diagnostics Gmbh Immunoassay using at least two pegylated analyte-specific binding agents
WO2019201901A1 (en) 2018-04-18 2019-10-24 F. Hoffmann-La Roche Ag Novel anti-thymidine kinase antibodies
WO2020043868A1 (en) 2018-08-31 2020-03-05 F. Hoffmann-La Roche Ag Thymidine kinase (tk-1) in prognostic indices for dlbcl
CN111272742A (en) * 2020-03-06 2020-06-12 安徽大学 Electrochemiluminescence sensor based on metal organic gel composite material and metal organic framework and preparation and detection methods thereof
WO2021013786A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013781A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Substance p as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013784A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a8 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013783A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013785A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a9 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021094409A1 (en) 2019-11-15 2021-05-20 F. Hoffmann-La Roche Ag Derivatization of beta-lactam antibiotics for massspec measurements in patient samples
WO2022090455A1 (en) 2020-11-02 2022-05-05 F. Hoffmann-La Roche Ag Sars-cov-2 nucleocapsid antibodies
US11366110B2 (en) 2011-01-11 2022-06-21 The Governing Council Of The University Of Toronto Protein detection method
US11391733B2 (en) 2015-08-20 2022-07-19 Roche Diagnostics Operations, Inc. Particle-based immunoassay using a pegylated analyte-specific binding agent
WO2022207685A1 (en) 2021-04-01 2022-10-06 F. Hoffmann-La Roche Ag Psp94 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2022207628A1 (en) 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Scf as blood biomarker for the non-invasive diagnosis of endometriosis
WO2022243210A1 (en) 2021-05-17 2022-11-24 F. Hoffmann-La Roche Ag sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS
CN115414930A (en) * 2022-08-26 2022-12-02 重庆医科大学 Ru(bpy) 32+ Anode or cathode coreactant and method of making same
WO2023072904A1 (en) 2021-10-26 2023-05-04 F. Hoffmann-La Roche Ag Monoclonal antibodies specific for sars-cov-2 rbd
WO2023131594A1 (en) 2022-01-05 2023-07-13 F. Hoffmann-La Roche Ag Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm)
WO2023247752A1 (en) 2022-06-23 2023-12-28 F. Hoffmann-La Roche Ag Method for diagnosing endometriosis and for classifying the stage of endometriosis
WO2024017983A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Meteorin-like protein (metrnl) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017985A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017982A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006075497A1 (en) * 2004-12-21 2006-07-20 Kyoto University Probe unit, apparatus for identifying nucleotide region and method of identifying nucleotide region

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591838A (en) * 1967-12-28 1971-07-06 Matsushita Electronics Corp Semiconductor device having an alloy electrode and its manufacturing method
US5019343A (en) * 1989-12-15 1991-05-28 W. R. Grace & Co.-Conn. Control of corrosion in aqueous systems using certain phosphonomethyl amines
US5124022A (en) * 1989-08-23 1992-06-23 Aluminum Company Of America Electrolytic capacitor and method of making same
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1993022678A2 (en) * 1992-04-23 1993-11-11 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591838A (en) * 1967-12-28 1971-07-06 Matsushita Electronics Corp Semiconductor device having an alloy electrode and its manufacturing method
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US5124022A (en) * 1989-08-23 1992-06-23 Aluminum Company Of America Electrolytic capacitor and method of making same
US5019343A (en) * 1989-12-15 1991-05-28 W. R. Grace & Co.-Conn. Control of corrosion in aqueous systems using certain phosphonomethyl amines
WO1993022678A2 (en) * 1992-04-23 1993-11-11 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL CHEMISTRY, Volume 66, Number 6, issued 15 March 1994, H. SU et al., "Interfacial Nucleic Acid Hybridization Studied by Random Primer 32P Labeling and Liquid-Phase Acoustic Network Analysis", pages 769-77. *
See also references of EP0777741A4 *

Cited By (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755458A4 (en) * 1995-02-09 2000-07-26 Igen Int Inc Electrogenerated chemiluminescence labels for analysis and/or referencing
EP0755458A1 (en) * 1995-02-09 1997-01-29 Igen, Inc. Electrogenerated chemiluminescence labels for analysis and/or referencing
US6066448A (en) * 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US6090545A (en) * 1995-03-10 2000-07-18 Meso Scale Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US7015046B2 (en) 1995-03-10 2006-03-21 Mesoscale Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6140045A (en) * 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
US6207369B1 (en) 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US7824925B2 (en) 1995-03-10 2010-11-02 Meso Scale Technology Llp Multi-array, multi-specific electrochemiluminescence testing
US8722323B2 (en) 1995-03-10 2014-05-13 Meso Scale Technologies Llp Multi-array, multi-specific electrochemiluminescence testing
US8541168B1 (en) 1995-03-10 2013-09-24 Jacob Wohlstadter Multi-array, multi-specific electrochemiluminescence testing
EP2284536A2 (en) 1996-09-17 2011-02-16 Meso Scale Technologies, LLC. Multi-array, multi-specific electrochemiluminescence testing
US6977151B2 (en) 1996-11-05 2005-12-20 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US6210932B1 (en) 1997-04-09 2001-04-03 Cis Bio International System for detecting nucleic acid hybridization, preparation method and application thereof
FR2762013A1 (en) * 1997-04-09 1998-10-16 Cis Bio Int NUCLEIC ACID HYBRIDIZATION DETECTION SYSTEMS, PROCESS FOR PREPARING THEM AND USES THEREOF
WO1998045475A1 (en) * 1997-04-09 1998-10-15 Cis Bio International System for detecting nucleic acid hybridisation, preparation method and application thereof
EP2284277A1 (en) 1997-12-23 2011-02-16 Meso Scale Technologies, LLC Methods and apparatus for improved luminescence assays using a soluble polymer having a ligand and a plurality of electrochemiluminescent labels
EP2186910A2 (en) 1997-12-23 2010-05-19 Meso Scale Technologies LLC Methods and compositions for improved luminescence assays using microparticles
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US9557295B2 (en) 1999-04-21 2017-01-31 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US9151746B2 (en) 1999-04-21 2015-10-06 Osmetech Technology, Inc. Use of microfluidic systems in the electrochemical detection of target analytes
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
WO2001042508A2 (en) * 1999-12-09 2001-06-14 Motorola, Inc. Methods and compositions relating to electrical detection of nucleic acid reactions
WO2001042508A3 (en) * 1999-12-09 2002-03-14 Motorola Inc Methods and compositions relating to electrical detection of nucleic acid reactions
US6518024B2 (en) 1999-12-13 2003-02-11 Motorola, Inc. Electrochemical detection of single base extension
US6824669B1 (en) 2000-02-17 2004-11-30 Motorola, Inc. Protein and peptide sensors using electrical detection methods
EP1322787A4 (en) * 2000-10-05 2005-06-15 Virginia Tech Intell Prop Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
EP1322787A1 (en) * 2000-10-05 2003-07-02 Virginia Tech Intellectual Properties, Inc. Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
US7138121B2 (en) 2003-01-23 2006-11-21 Spangler Brenda D Biosensors utilizing dendrimer-immobilized ligands and there use thereof
US7741033B2 (en) * 2003-05-13 2010-06-22 Trustees Of Boston College Electrocatalytic nucleic acid hybridization detection
US7361470B2 (en) 2003-05-13 2008-04-22 Trustees Of Boston College Electrocatalytic nucleic acid hybridization detection
WO2006076047A3 (en) * 2004-08-06 2009-04-09 Trustees Boston College Electrocatalytic nucleic acid hybridization detection
US9791402B2 (en) 2008-09-02 2017-10-17 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biosensing devices incorporating the same
US8888969B2 (en) 2008-09-02 2014-11-18 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biosensing devices incorporating the same
US10274453B2 (en) 2008-09-02 2019-04-30 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biosensing devices incorporating the same
US11366110B2 (en) 2011-01-11 2022-06-21 The Governing Council Of The University Of Toronto Protein detection method
US10301666B2 (en) 2011-03-10 2019-05-28 General Atomics Diagnostic and sample preparation devices and methods
US9580742B2 (en) 2011-03-10 2017-02-28 Shana O. Kelley Diagnostic and sample preparation devices and methods
US11391733B2 (en) 2015-08-20 2022-07-19 Roche Diagnostics Operations, Inc. Particle-based immunoassay using a pegylated analyte-specific binding agent
WO2017153336A1 (en) 2016-03-07 2017-09-14 F. Hoffmann-La Roche Ag Detection of anti-p53 antibodies
WO2018141768A1 (en) 2017-02-02 2018-08-09 Roche Diagnostics Gmbh Immunoassay using at least two pegylated analyte-specific binding agents
US11099180B2 (en) 2017-02-02 2021-08-24 Roche Diagnostics Operations, Inc. Immunoassay using at least two pegylated analyte-specific binding agents
WO2019201901A1 (en) 2018-04-18 2019-10-24 F. Hoffmann-La Roche Ag Novel anti-thymidine kinase antibodies
WO2020043868A1 (en) 2018-08-31 2020-03-05 F. Hoffmann-La Roche Ag Thymidine kinase (tk-1) in prognostic indices for dlbcl
WO2021013786A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013783A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013785A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a9 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013784A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a8 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013781A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Substance p as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021094409A1 (en) 2019-11-15 2021-05-20 F. Hoffmann-La Roche Ag Derivatization of beta-lactam antibiotics for massspec measurements in patient samples
CN111272742A (en) * 2020-03-06 2020-06-12 安徽大学 Electrochemiluminescence sensor based on metal organic gel composite material and metal organic framework and preparation and detection methods thereof
CN111272742B (en) * 2020-03-06 2022-11-08 安徽大学 Electrochemiluminescence sensor based on metal organic gel composite material and metal organic framework and preparation and detection methods thereof
WO2022090455A1 (en) 2020-11-02 2022-05-05 F. Hoffmann-La Roche Ag Sars-cov-2 nucleocapsid antibodies
WO2022207628A1 (en) 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Scf as blood biomarker for the non-invasive diagnosis of endometriosis
WO2022207685A1 (en) 2021-04-01 2022-10-06 F. Hoffmann-La Roche Ag Psp94 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2022243210A1 (en) 2021-05-17 2022-11-24 F. Hoffmann-La Roche Ag sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS
WO2023072904A1 (en) 2021-10-26 2023-05-04 F. Hoffmann-La Roche Ag Monoclonal antibodies specific for sars-cov-2 rbd
WO2023131594A1 (en) 2022-01-05 2023-07-13 F. Hoffmann-La Roche Ag Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm)
WO2023247752A1 (en) 2022-06-23 2023-12-28 F. Hoffmann-La Roche Ag Method for diagnosing endometriosis and for classifying the stage of endometriosis
WO2024017983A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Meteorin-like protein (metrnl) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017985A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017982A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
CN115414930A (en) * 2022-08-26 2022-12-02 重庆医科大学 Ru(bpy) 32+ Anode or cathode coreactant and method of making same
CN115414930B (en) * 2022-08-26 2023-10-31 重庆医科大学 Ru(bpy) 32+ Anode or cathode coreactant and method for producing same

Also Published As

Publication number Publication date
EP0777741A4 (en) 1999-01-13
JPH10509025A (en) 1998-09-08
AU3410395A (en) 1996-03-22
AU703344B2 (en) 1999-03-25
EP0777741A1 (en) 1997-06-11
CA2198489A1 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
AU703344B2 (en) Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface
Xu et al. Immobilization and hybridization of DNA on an aluminum (III) alkanebisphosphonate thin film with electrogenerated chemiluminescent detection
US6127127A (en) Monolayer and electrode for detecting a label-bearing target and method of use thereof
US7829275B2 (en) Light addressable electrochemical detection of duplex structures
US7160678B1 (en) Compositions for the electronic detection of analytes utilizing monolayers
US6096500A (en) Multi-label complex for enhanced sensitivity in electrochemiluminescence assay
US7393645B2 (en) Compositions for the electronic detection of analytes utilizing monolayers
US6387625B1 (en) Monolayer and electrode for detecting a label-bearing target and method of use thereof
JP2002513916A (en) Electronic detection of analytes using monolayers
Duman et al. A new approach for immobilization of oligonucleotides onto piezoelectric quartz crystal for preparation of a nucleic acid sensor for following hybridization
Szymczyk et al. Further insight into the possible influence of electrode blocking agents on the stem-loop based electrochemical DNA sensor parameters
KR100459394B1 (en) Electrochemiluminescence detection method for a nucleic acid using an intercalator
Spehar-Deleze et al. Electrochemiluminescent hybridization chip with electric field aided mismatch discrimination
WO2010117341A1 (en) Nucleic acid biosensor
AU3676799A (en) Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to solid surface
Brett et al. Synthetic oligonucleotides: AFM characterisation and electroanalytical studies
Palchetti et al. Electrochemical adsorption technique for immobilization of single-stranded oligonucleotides onto carbon screen-printed electrodes
WO2005042783A1 (en) Temperature-jump enhanced electrochemical detection of nucleic acid hybridization
US20040175742A1 (en) Biosensor and method for detecting macromolecular biopolymers using at least one unit for immobilizing macromolecular biopolymers
US7321831B2 (en) Nucleic acid fragment-fixed electrode and its use
WONG Recent trends in DNA biosensing technologies
Zarei Development of Light-Addressable Electrode Arrays Towards the Application of DNA Hybridization Biosensor
US20070077593A1 (en) Substrate as a ligate carrier
CN116376552A (en) Monoatomic electrochemiluminescence probe and preparation method and application thereof
Bronder Label-free detection of tuberculosis DNA with capacitive field-effect biosensors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2198489

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1995930881

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995930881

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1995930881

Country of ref document: EP